ESPERION The Lipid Management Company
Twitter LinkedIn Youtube
SEARCH
IMPORTANT NOTICE ABOUT IMPERSONATION SCAMS: Unauthorized individuals or entities are impersonating ESPERION colleagues through spoofed email, text messages and social media in an effort to gain access to bank account information and/or other personal information. Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov.
  • Products
    Nexletol Nexlizet
  • Science
    BEMPEDOIC ACID Bempedoic Acid/
    Ezetimibe combo
    tablet
    Clinical Trials Compassionate Use Oral PCSK9 Inhibitor
  • Unmet Need
    Lipid Management
  • The Esperion Story
    The Esperion Story Leadership Team Board of directors Careers Ethics and Compliance Contact Us
  • GRANTS
    Application
    Information
  • Investors & Media
    Investors Overview Press Releases Events & Presentations Stock Information Financial Information Corporate Governance Media Kit Analyst Coverage FAQs

NEXLETOL NEXLIZET
Bempedoic Acid Bempedoic Acid/Ezetimibe combo tablet Clinical Trials Compassionate Use Oral PCSK9 Inhibitor
LIPID MANAGEMENT
The Esperion Story Leadership Team Board of directors Careers Ethics and Compliance Contact Us
Application Information
Investors Overview Press Releases Events & Presentations Stock Information Financial Information Corporate Governance Media Kit Analyst Coverage FAQs

Nexletol Nexlizet
BEMPEDOIC ACID Bempedoic Acid/
Ezetimibe combo
tablet
Clinical Trials Compassionate Use Oral PCSK9 Inhibitor

Lipid Management
The Esperion Story Leadership Team Board of directors Careers Ethics and Compliance Contact Us
Application Information
Investors Overview Press Releases Events & Presentations Stock Information Financial Information Corporate Governance Media Kit Analyst Coverage FAQs
PRODUCTS
Nexletol Nexlizet
SCIENCE
Bempedoic acid Bempedoic acid/
Ezetimibe Combo
Tablet
Clinical Trials Compassionate Use Oral PCSK9 Inhibitor
UNMET NEED
Lipid management
THE ESPERION STORY
The Esperion story Leadership team Board of directors Careers Ethics and Compliance Contact Us
GRANTS
Application Information
INVESTORS & MEDIA
Investors Overview Press Releases Events & presentations Stock information Financial Information Corporate Governance Media Kit Analyst Coverage FAQs
All trademarks and trade names are the property of their respective owners.
Ⓒ 2020 ESPERION Therapeutics, Inc.
All rights reserved. 05/20 US-CRP-2000082

Privacy Policy Terms of Use
We use cookies to offer you a better online experience, analyze site traffic, and serve targeted advertisements. By continuing to use this website, you consent to our use of cookies in accordance with our cookie and Privacy Policy.
I accept
all cookies
We use cookies to offer you a better online experience, analyze site traffic, and serve targeted advertisements. By continuing to use this website, you consent to our use of cookies in accordance with our cookie and Privacy Policy.
 
Stay in the Know
 
For updates about ESPERION regarding our latest developments and product information, sign-up below.

All fields are required.
Oops! We need this information.
Oops! We need this information.
Oops! We need this information.
Oops! We need this information.
Oops! We need this information.
KEEP ME IN THE KNOW
Oops! We need this information.
Thank You
Thank you for your interest in ESPERION!
It's a very exciting time for us and we're eager to share updates with you as soon as possible at .
Oops! Something went wrong, please try again.